What does Dr. EECLOO do?

Dr. EECLOO is a general practice in Zwevegem. Private Limited, started on 4 September 2018, 1 establishment.

What is the address of Dr. EECLOO?

The registered office of Dr. EECLOO is located at Broekenhoek(M) 12, 8552 Zwevegem.

Is Dr. EECLOO still active?

Yes. According to the CBE (18 September 2026) Dr. EECLOO is active, legal situation “Normale toestand”, started on 4 September 2018.

Is Dr. EECLOO registered on Peppol?

Yes, Dr. EECLOO is registered on the Peppol network with ID 0208:0702769651.

What is the enterprise number of Dr. EECLOO?

The enterprise number of Dr. EECLOO is BE0702769651.

When was Dr. EECLOO founded?

Dr. EECLOO was founded on 4 September 2018.

Who are the directors of Dr. EECLOO?

According to the 2025 annual accounts, the directors of Dr. EECLOO are: LIEZE EECLOO.

Is Dr. EECLOO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 September 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. EECLOO make in 2025?

Dr. EECLOO posted a profit after taxes of € 145,305 in financial year 2025.

What is the revenue of Dr. EECLOO?

As a small company, Dr. EECLOO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 200,064.

Dr. EECLOO (Private Limited) - Zwevegem - BE0702769651

Dossier Dr. EECLOO, printed on 18 September 2026 from databakkes.be/en/0702769651/dr-eecloo. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. EECLOO from Zwevegem, company number BE0702769651, closed financial year 2025 with a result of € 145,305 after tax. For that financial year Dr. EECLOO recorded a gross margin of € 200,064 and equity of € 163,905. Compared with financial year 2024, the result moved from € 131,094 to € 145,305. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 29, 2026.

What it is worth Healthy

€ 163,905

▼ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 145,305

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 13,754

▼ 52% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 149,609 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 37,585

▲ € 33,695 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 62,971

▲ 39% vs 2024

€ 18,339 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 1,304

▼ 24% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,650

▼ 81% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 95,804 Gross margin 2022: € 95,804 First fiscal year in the series	€ 166,400 Gross margin 2023: € 166,400 ▲ 74% vs 2022 (€ 95,804) Favourable step	€ 187,362 Gross margin 2024: € 187,362 ▲ 13% vs 2023 (€ 166,400) Favourable step	€ 200,064 Gross margin 2025: € 200,064 ▲ 7% vs 2024 (€ 187,362) Favourable step	▲ 7%
Profit after taxes	€ 67,714 Profit after taxes 2022: € 67,714 First fiscal year in the series	€ 118,697 Profit after taxes 2023: € 118,697 ▲ 75% vs 2022 (€ 67,714) Favourable step	€ 131,094 Profit after taxes 2024: € 131,094 ▲ 10% vs 2023 (€ 118,697) Favourable step	€ 145,305 Profit after taxes 2025: € 145,305 ▲ 11% vs 2024 (€ 131,094) Favourable step	▲ 11%
Equity	€ 320,110 Equity 2022: € 320,110 First fiscal year in the series	€ 437,973 Equity 2023: € 437,973 ▲ 37% vs 2022 (€ 320,110) Favourable step	€ 168,209 Equity 2024: € 168,209 ▼ 62% vs 2023 (€ 437,973) Unfavourable step	€ 163,905 Equity 2025: € 163,905 ▼ 3% vs 2024 (€ 168,209) Unfavourable step	▼ 3%
Total debts	€ 115,913 Total debts 2022: € 115,913 First fiscal year in the series	€ 116,297 Total debts 2023: € 116,297 Unchanged (€ 115,913) Unfavourable step	€ 109,069 Total debts 2024: € 109,069 ▼ 6% vs 2023 (€ 116,297) Favourable step	€ 146,942 Total debts 2025: € 146,942 ▲ 35% vs 2024 (€ 109,069) Unfavourable step	▲ 35%
Cash	€ 193,574 Cash 2022: € 193,574 First fiscal year in the series	€ 310,140 Cash 2023: € 310,140 ▲ 60% vs 2022 (€ 193,574) Favourable step	€ 28,742 Cash 2024: € 28,742 ▼ 91% vs 2023 (€ 310,140) Unfavourable step	€ 13,754 Cash 2025: € 13,754 ▼ 52% vs 2024 (€ 28,742) Unfavourable step	▼ 52%
Retained profit	€ 301,510 Retained profit 2022: € 301,510 First fiscal year in the series	€ 419,373 Retained profit 2023: € 419,373 ▲ 39% vs 2022 (€ 301,510) Favourable step	€ 149,609 Retained profit 2024: € 149,609 ▼ 64% vs 2023 (€ 419,373) Unfavourable step	€ 145,305 Retained profit 2025: € 145,305 ▼ 3% vs 2024 (€ 149,609) Unfavourable step	▼ 3%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▲ 4% vs 2022 (€ 800) Unchanged	€ 400,859 Dividend 2024: € 400,859 ▲ € 400,026 vs 2023 (€ 833) Unchanged	€ 149,609 Dividend 2025: € 149,609 ▼ 63% vs 2024 (€ 400,859) Unchanged	▼ 63%
Bank debt	€ 67,307 Bank debt 2022: € 67,307 First fiscal year in the series	€ 56,339 Bank debt 2023: € 56,339 ▼ 16% vs 2022 (€ 67,307) Favourable step	€ 45,429 Bank debt 2024: € 45,429 ▼ 19% vs 2023 (€ 56,339) Favourable step	€ 62,971 Bank debt 2025: € 62,971 ▲ 39% vs 2024 (€ 45,429) Unfavourable step	▲ 39%
Balance sheet total	€ 436,023 Balance sheet total 2022: € 436,023 First fiscal year in the series	€ 554,271 Balance sheet total 2023: € 554,271 ▲ 27% vs 2022 (€ 436,023) Unchanged	€ 277,278 Balance sheet total 2024: € 277,278 ▼ 50% vs 2023 (€ 554,271) Unchanged	€ 310,846 Balance sheet total 2025: € 310,846 ▲ 12% vs 2024 (€ 277,278) Unchanged	▲ 12%

Key figures of Dr. EECLOO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. EECLOO?

What happened at Dr. EECLOO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 29, 2026 New annual accounts for financial year 2025: profit of € 145,305 (▲ 11% vs 2024). Source: NBB ↗
Sep 4, 2018 New establishment in Zwevegem. KBO
Sep 4, 2018 Start of the company according to the CBE. KBO

In short

From € 67,714 profit in 2022 to € 145,305 profit in 2025.

Paid € 159,776 in corporate taxes since 2022.

Best year ever: 2025, with € 145,305 profit.

Paid out € 552,101 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. EECLOO? We notify you, reason included.

Follow Dr. EECLOO

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

LIEZE EECLOO

Dr. EECLOO

ARCUS 20%

Behind Dr. EECLOO is LIEZE EECLOO. It owns 20% of ARCUS itself.

See the full network in the app

Directors

According to the 2025 annual accounts

LIEZE EECLOO

Director

Also active at: ARCUS

Establishments

Establishment units

Physical locations of this company

Registered office

Broekenhoek(M) 12

8552 Zwevegem

2.279.433.979

Oude Bellegemstraat(Z) 31

8550 Zwevegem

Active since 4 September 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0702.769.651
VAT number: BE 0702.769.651
Registered office: Broekenhoek(M) 12, 8552 Zwevegem
Names & denominations: Dr. EECLOO
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 September 2018
Peppol: Active · Active since 5 Feb 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗